Management Options for Attention Deficit/Hyperactivity

Abstract and Introduction

Introduction

A wide array of products are currently on the market in the United States for the management of ADHD. Over the past decade, a number of new treatment options have been introduced, including once-daily products, oral liquid and transdermal dosage formulations, and several generic products (Table). This issue of Pediatric Pharmacotherapy will provide a brief review of some of these products and highlight their unique properties.